One of the key drivers for the growth of the OTC analgesics market is the increasing prevalence of migraines and headaches globally. According to the Global Burden of Disease Study 2016, published in
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |